APA (7th ed.) Citation

AE, E., SS, S., HA, I., & SE, A. (2020). Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice. Naunyn-Schmiedeberg's archives of pharmacology, 393(6), 1113. https://doi.org/10.1007/s00210-019-01803-2

Chicago Style (17th ed.) Citation

AE, El-Sisi, Sokar SS, Ibrahim HA, and Abu-Risha SE. "Enhanced Anticancer Activity of Combined Treatment of Imatinib and Dipyridamole in Solid Ehrlich Carcinoma-bearing Mice." Naunyn-Schmiedeberg's Archives of Pharmacology 393, no. 6 (2020): 1113. https://doi.org/10.1007/s00210-019-01803-2.

MLA (9th ed.) Citation

AE, El-Sisi, et al. "Enhanced Anticancer Activity of Combined Treatment of Imatinib and Dipyridamole in Solid Ehrlich Carcinoma-bearing Mice." Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 393, no. 6, 2020, p. 1113, https://doi.org/10.1007/s00210-019-01803-2.